BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martins SF, Reis RM, Rodrigues AM, Baltazar F, Filho AL. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies. World J Clin Oncol 2011; 2(6): 272-280 [PMID: 21773077 DOI: 10.5306/wjco.v2.i6.272] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Martins SF, Mariano V, Rodrigues M, Longatto-Filho A. Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma. Infect Agent Cancer 2020;15:17. [PMID: 32165915 DOI: 10.1186/s13027-020-00281-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Gurzu S, Cimpean AM, Kovacs J, Jung I. Counting of angiogenesis in colorectal carcinomas using double immunostain. Tumori 2012;98:485-90. [PMID: 23052166 DOI: 10.1700/1146.12644] [Reference Citation Analysis]
3 Lai E, Cascinu S, Scartozzi M. Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice. Front Oncol 2021;11:637823. [PMID: 34041019 DOI: 10.3389/fonc.2021.637823] [Reference Citation Analysis]
4 Surov A, Wienke A. Associations Between FDG PET and Expression of VEGF and Microvessel Density in Different Solid Tumors: A Meta-analysis. Acad Radiol 2021;28:e110-7. [PMID: 32327296 DOI: 10.1016/j.acra.2020.02.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cartana ET, Gheonea DI, Cherciu IF, Streaţa I, Uscatu CD, Nicoli ER, Ioana M, Pirici D, Georgescu CV, Alexandru DO, Şurlin V, Gruionu G, Săftoiu A. Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis. Endosc Ultrasound 2018;7:175-83. [PMID: 28685747 DOI: 10.4103/eus.eus_7_17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 Dinami R, Porru M, Amoreo CA, Sperduti I, Mottolese M, Buglioni S, Marinelli D, Maugeri-Saccà M, Sacconi A, Blandino G, Leonetti C, Di Rocco G, Verdina A, Spinella F, Fiorentino F, Ciliberto G, Biroccio A, Zizza P. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. J Exp Clin Cancer Res 2020;39:111. [PMID: 32539869 DOI: 10.1186/s13046-020-01612-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, Persano M, Pinna G, Balconi F, Pireddu A, Impera V, Dubois M, Migliari M, Spanu D, Saba G, Camera S, Musio F, Ziranu P, Puzzoni M, Demurtas L, Pusceddu V, Dettori M, Massa E, Atzori F, Dessì M, Astara G, Madeddu C, Scartozzi M. Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1214. [PMID: 32413973 DOI: 10.3390/cancers12051214] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
8 He K, Cui B, Li G, Wang H, Jin K, Teng L. The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC). Onco Targets Ther 2012;5:59-65. [PMID: 22570554 DOI: 10.2147/OTT.S29719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
9 Marioni G, Ottaviano G, Marchese-ragona R, Fasanaro E, Tealdo G, Zanotti C, Randon B, Giacomelli L, Stellini E, Blandamura S. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma. J Clin Pathol 2017;70:1033-7. [DOI: 10.1136/jclinpath-2016-204230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Lin Y, He Z, Ye J, Liu Z, She X, Gao X, Liang R. Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. Onco Targets Ther 2020;13:13023-32. [PMID: 33376351 DOI: 10.2147/OTT.S278013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mazeda I, Martins SF, Garcia EA, Rodrigues M, Longatto A. VEGF Expression in Colorectal Cancer Metastatic Lymph Nodes: Clinicopathological Correlation and Prognostic Significance. GastrointestDisord 2020;2:267-80. [DOI: 10.3390/gidisord2030025] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Barbara RC, Piotr R, Kornel B, Elżbieta Z, Danuta R, Eduardo N. Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes. J Clin Med 2020;9:E1708. [PMID: 32498398 DOI: 10.3390/jcm9061708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Caulet M, Lecomte T, Bouché O, Rollin J, Gouilleux-Gruart V, Azzopardi N, Léger J, Borg C, Douillard JY, Manfredi S, Smith D, Capitain O, Ferru A, Moussata D, Terrebone E, Paintaud G, Ternant D. Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients. Clin Pharmacokinet 2016;55:1381-94. [PMID: 27312193 DOI: 10.1007/s40262-016-0406-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
14 Jeong E, Lee H, Pyee J, Park H. Pinosylvin Induces Cell Survival, Migration and Anti-Adhesiveness of Endothelial Cells via Nitric Oxide Production: PINOSYLVIN IS A VASOREGULATING COMPOUND. Phytother Res 2013;27:610-7. [DOI: 10.1002/ptr.4770] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
15 Jürgensmeier JM, Schmoll HJ, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. Br J Cancer. 2013;108:1316-1323. [PMID: 23449351 DOI: 10.1038/bjc.2013.79] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
16 Lindgren A, Anttila M, Rautiainen S, Arponen O, Kivelä A, Mäkinen P, Härmä K, Hämäläinen K, Kosma VM, Ylä-Herttuala S, Vanninen R, Sallinen H. Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI. Eur Radiol 2017;27:4002-12. [PMID: 28289938 DOI: 10.1007/s00330-017-4786-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
17 Kocael A, Vatankulu B, Şimşek O, Cengiz M, Kemik A, Kocael P, Halaç M, Sönmezoğlu K, Ulualp K. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer. Tumour Biol 2016;37:3871-7. [PMID: 26476536 DOI: 10.1007/s13277-015-4218-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ortiz-morales MJ, Toledano-fonseca M, Mena-osuna R, Cano MT, Gómez-españa A, Haba-rodríguez JRDL, Rodríguez-ariza A, Aranda E. Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab. Cancers 2022;14:3054. [DOI: 10.3390/cancers14133054] [Reference Citation Analysis]
19 Martins SF, Amorim R, Mota SC, Costa L, Pardal F, Rodrigues M, Longatto-Filho A. Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival. Biomed Res Int 2015;2015:131685. [PMID: 26448927 DOI: 10.1155/2015/131685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Rakocevic J, Orlic D, Mitrovic-Ajtic O, Tomasevic M, Dobric M, Zlatic N, Milasinovic D, Stankovic G, Ostojić M, Labudovic-Borovic M. Endothelial cell markers from clinician's perspective. Exp Mol Pathol 2017;102:303-13. [PMID: 28192087 DOI: 10.1016/j.yexmp.2017.02.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
21 Aghamohammadi A, Hosseinimehr SJ. Antiangiogenic Agents in Natural Products for the Treatment of Gynecologic Disorders. Nutrition and Cancer 2013;66:206-13. [DOI: 10.1080/01635581.2014.865136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Lamberti MJ, Pansa MF, Vera RE, Vittar NBR, Rivarola VA. Photodynamic therapy potentiates the paracrine endothelial stimulation by colorectal cancer. Laser Phys 2014;24:115602. [DOI: 10.1088/1054-660x/24/11/115602] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
23 Samaka RM, Abd El-Wahed MM, Aiad HA, Kandil MA, Al-Sharaky DR. Does JC virus have a role in the etiology and prognosis of Egyptian colorectal carcinoma? APMIS 2013;121:316-28. [PMID: 23030805 DOI: 10.1111/apm.12001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
24 Goulart A, Ferreira C, Rodrigues A, Coimbra B, Sousa N, Leão P. The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer. Ann Surg Treat Res 2019;97:15-20. [PMID: 31297348 DOI: 10.4174/astr.2019.97.1.15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
25 Martinovic Z, Kovac D, Martinovic M. Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis. Gastroenterol Res Pract 2015;2015:504179. [PMID: 26089870 DOI: 10.1155/2015/504179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]